2-AMino-1-((R)-3-diMethylaMino-pyrrolidin-1-yl)-ethanone
|
- $1499
- Product name: 2-AMino-1-((R)-3-diMethylaMino-pyrrolidin-1-yl)-ethanone
- CAS: 1354010-68-6
- MF: C8H17N3O
- MW: 171.24
- EINECS:
- MDL Number:MFCD21096598
- Synonyms:2-AMino-1-((R)-3-diMethylaMino-pyrrolidin-1-yl)-ethanone;Ethanone, 2-amino-1-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerChemenu
- Product numberCM498671
- Product description(R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1499
- Updated2026-05-26
- Buy
- ManufacturerChemenu
- Product numberCM498671
- Product description(R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1499
- Updated2026-05-20
- Buy
- ManufacturerCrysdot
- Product numberCD11283186
- Product description(R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1499
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11283186
- Product description(R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97%
- Packaging1g
- Price$1499
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM498671 | (R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97% | 1g | $1499 | 2026-05-26 | Buy |
| Chemenu | CM498671 | (R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97% | 1g | $1499 | 2026-05-20 | Buy |
| Crysdot | CD11283186 | (R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97% | 1g | $1499 | 2026-05-26 | Buy |
| Crysdot | CD11283186 | (R)-2-Amino-1-(3-(dimethylamino)pyrrolidin-1-yl)ethanone 97% | 1g | $1499 | 2021-12-16 | Buy |
Properties
Boiling point :304.1±37.0 °C(Predicted)
Density :1.09±0.1 g/cm3(Predicted)
pka :8.46±0.20(Predicted)
Density :1.09±0.1 g/cm3(Predicted)
pka :8.46±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|